| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
13,917,000 | 13,637,000 | 14,513,000 | 14,719,000 | 14,097,000 |
Cost of Goods Sold (COGS) incl. D&A |
12,056,000 | 11,460,000 | 12,322,000 | 12,397,000 | 12,057,000 |
COGS excluding D&A |
11,376,000 | 10,795,000 | 11,648,000 | 11,718,000 | 11,792,000 |
Depreciation & Amortization Expense |
680,000 | 665,000 | 674,000 | 679,000 | 265,000 |
Gross Income |
1,861,000 | 2,177,000 | 2,191,000 | 2,322,000 | 2,040,000 |
SG&A Expense |
1,204,000 | 1,171,000 | 1,080,000 | 1,112,000 | 1,135,000 |
Research & Development |
463,000 | 434,000 | 406,000 | 405,000 | 433,000 |
Other SG&A |
741,000 | 737,000 | 674,000 | 707,000 | 702,000 |
Other Operating Expense |
0 | 0 | 0 | 0 | 628,000 |
Unusual Expense |
1,367,000 | 27,000 | 0 | 367,000 | -28,000 |
Non Operating Income/Expense |
22,000 | -21,000 | 27,000 | 13,000 | 117,000 |
Equity in Affiliates (Pretax) |
133,000 | 175,000 | 148,000 | 169,000 | 0 |
Interest Expense |
310,000 | 318,000 | 312,000 | 325,000 | 348,000 |
Gross Interest Expense |
310,000 | 318,000 | 312,000 | 325,000 | 348,000 |
Pretax Income |
-850,000 | 825,000 | 984,000 | 706,000 | 74,000 |
Income Tax |
-99,000 | 234,000 | 244,000 | 186,000 | 271,000 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 280,000 |
Consolidated Net Income |
-749,000 | 586,000 | 740,000 | 516,000 | 113,000 |
Minority Interest Expense |
-120,000 | 9,000 | 6,000 | 23,000 | 18,000 |
Net Income |
-629,000 | 577,000 | 734,000 | 493,000 | 95,000 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | NA | 0 | 0 |
Net Income After Extraordinaries |
-629,000 | 577,000 | 734,000 | 493,000 | 95,000 |
Preferred Dividends |
85,000 | 85,000 | 85,000 | 85,000 | 115,000 |
Net Income available to Common |
-714,000 | 492,000 | 649,000 | 408,000 | -20,000 |
Operational EPS |
0.21 | 0.43 | 0.55 | 0.57 | -0.03 |
EPS (basic) |
-0.61 | 0.42 | 0.55 | 0.35 | -0.02 |
EBITDA |
1,337,000 | 1,671,000 | 1,785,000 | 1,889,000 | 542,000 |
Depreciation & Amortization Expense |
680,000 | 665,000 | 674,000 | 679,000 | 265,000 |
Common Shares Outstanding |
1,176,400 | 1,179,500 | 1,176,600 | 1,168,700 | 1,158,200 |
Basic Shares Outstanding |
1,170,491 | 1,172,700 | 1,169,700 | 1,160,900 | 1,149,000 |
Diluted Shares Outstanding |
1,176,400 | 1,179,500 | 1,176,600 | 1,168,700 | 1,158,200 |
Diluted EPS after Extraordinary Items |
-0.61 | 0.42 | 0.55 | 0.35 | -0.02 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
-0.54 | 0.49 | 0.63 | 0.42 | -0.02 |
*Figures in thousands of U.S. Dollars except shares outstanding.
